1. P-098TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441). (2nd July 2019) Authors: Hammel, P; Feliu, J; Parner, V; Berardi, R; Van Cutsem, E; Greil, R; Wasan, H; Metges, J; Nygren, P; Osterlund, P; Seufferlein, T; Creemers, G; Biswas-Baldwin, N; Youssoufian, H; Gupta, A; Salesse, S; Dion, H; El-Hariry, I; Hidalgo, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗